Skip to content

Blood Flow Restriction Resistance Exercise and Cardiac Cycle Dynamics

Blood Flow Restriction Resistance Exercise and Cardiac Cycle Dynamics

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07344740
Enrollment
40
Registered
2026-01-15
Start date
2026-02-01
Completion date
2028-01-01
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac

Brief summary

Blood flow restriction resistance exercise uses partial vascular occlusion of a limb during low weight resistance exercises to stimulate muscle strengthening and growth. This is commonly used during rehabilitation from an injury. Because blood flow in and out of the limbs is decreased, this may have consequences for blood flow through the heart. The purpose of this study will be to test cardiac dynamics during blood flow restriction resistance exercise to determine if cardiac blood flow is impacted. It is hypothesized that both non-BFR exercise and BFR exercise will increase heart rate shortening various cardiac cycle parameters, but BFR exercise will increase the isovolumetric contraction time vs non-BFR exercise due to an increase in total peripheral resistance. It is also hypothesized that BFR exercise will lower early ventricular filling parameters due to lower venous return.

Interventions

Blood flow in and out of the limb will be artificially with an occlusion cuff.

Sponsors

Montclair State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Generally healthy

Exclusion criteria

* Uncontrolled hypertension * Peripheral vascular disease * Lymphedema * Sickle cell anemia * Heart failure * Stroke history * Heart attack history * Rheumatoid arthritis * Chronic kidney disease * Diabetes * Severe neuropathy * Any condition that may make blood flow restriction resistance exercise riskier like history of blood clots * Use of coagulant therapy * Susceptible to blood clots * Obesity

Design outcomes

Primary

MeasureTime frame
Cardiac cycle durationsDuring the intervention for approximately 10 minutes.
Ventricular fillingDuring intervention phase for approximately 10 minutes.

Countries

United States

Contacts

CONTACTEvan Matthews
matthewse@montclair.edu17406328709

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026